[Clinical use of Eksalb for the donor site in intermediate skin grafts].
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007809:Lanolin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010577:Petrolatum / Q000627:therapeutic use; D011182:Postoperative Care; D016038:Skin Transplantation; D013518:Surgery, Plastic; D014182:Transplantation, Autologous
D003879:Dermatologic Agents; D007809:Lanolin; D010577:Petrolatum